Mechanisms of developing post-traumatic stress disorder: New targets for drug development and other potential interventions

CNS and Neurological Disorders - Drug Targets

Volumn 13, Issue 5, 2014, Pages 807-816

  Wimalawansa, Sunil J ^a  

^a Cardio Metabolic Institute   (United States)

Author keywords

Cytokines; Homeostasis; Hormones; Neurons; Psychiatry; Stress; Structure function; Trauma

Indexed keywords

CATECHOLAMINE; GLUCOCORTICOID; NEUROPEPTIDE Y; NEUROTRANSMITTER; HORMONE;

AMYGDALOID NUCLEUS; ARTICLE; CHRONIC STRESS; CORTICOSTEROID BLOOD LEVEL; DEPRESSION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC SUSCEPTIBILITY; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MITOCHONDRIAL ENERGY TRANSFER; NERVE CELL PLASTICITY; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; WORKING MEMORY; ANIMAL; BRAIN; DRUG DEVELOPMENT; DRUG EFFECTS; GENETICS; METABOLISM; STRESS DISORDERS, POST-TRAUMATIC;

ANIMALS; BRAIN; DRUG DISCOVERY; HORMONES; HUMANS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84905581074     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527313666140711091026     Document Type: Article

References (121)

1. Ohayon MM, Shapiro CM. Sleep disturbances and psychiatric disorders associated with posttraumatic stress disorder in the general population. Compr Psychiatry 2000; 41: 469-78.
2. Schnurr PP, Lunney CA, Sengupta A. Risk factors for the development versus maintenance of posttraumatic stress disorder. J Traumatic Stress 2004; 17: 85-95.
3. McHugh T, Forbes D, Bates G, Hopwood M, Creamer M. Anger in PTSD: is there a need for a concept of PTSD-related posttraumatic anger? Clin Psychol Rev 2012; 32: 93-104.
4. Bachynski KE, Canham-Chervak M, Black SA, et al. Mental health risk factors for suicides in the US Army, 2007-8. Inj Prev 2012; 18: 405-12.
5. Wimalawansa SJ. Post-Traumatic Stress Disorder: An Under-Diagnosed and Under-Treated Entity. Compr Res J Med Med Sci 2013; 1(12): 11.
6. Neria Y, DiGrande L, Adams BG. Posttraumatic stress disorder following the September 11, 2001, terrorist attacks: a review of the literature among highly exposed populations. Am Psychol 2011; 66: 429-46.
7. Giardino AE. Combat veterans, mental health issues, and the death penalty: addressing the impact of post-traumatic stress disorder and traumatic brain injury. Fordham Law Rev 2009; 77: 2955-95.
8. Delimar D, Sivik T, Korenjak P, Delimar N. The effect of different traumatic experiences on the development of post-traumatic stress disorder. Mil Med 1995; 160: 635-9.
9. Oquendo MA, Friend JM, Halberstam B, et al. Association of comorbid posttraumatic stress disorder and major depression with greater risk for suicidal behavior. Am J Psychiatry 2003; 160: 580-2.
10. Oquendo M, Brent DA, Birmaher B, et al. Posttraumatic stress disorder comorbid with major depression: factors mediating the association with suicidal behavior. Am J Psychiatry 2005; 162: 560-6.
11. Jain S. ICD11 and DSM5: The Indian dilemma. Asian J Psychiatry 2013; 6: 269-70.
12. Otto MW, Henin A, Hirshfeld-Becker DR, et al. Posttraumatic stress disorder symptoms following media exposure to tragic events: impact of 9/11 on children at risk for anxiety disorders. J Anxiety Disord 2007; 21: 888-902.
13. Saylor C, DeRoma V, Swickert R. College students with previous exposure to crime report more PTSD after 9-11-2001. Psychol Rep 2006; 99: 581-2.
14. Das A. Pharmaceutical industry and the market: The case of Prozac and other antidepressants. Asian J Psychiatry 2011; 4: 14-8.
15. van Zuiden M, Kavelaars A, Geuze E, Olff M, Heijnen CJ. Predicting PTSD: Pre-existing vulnerabilities in glucocorticoid-signaling and implications for preventive interventions. Brain Behav Immun 2012; 5: 16.
16. Franklin CL, Young D, Zimmerman M. Psychiatric patients' vulnerability in the wake of the September 11th terrorist attacks. J Nerv Ment Dis 2002; 190: 833-8.
17. Steenkamp MM, Nickerson A, Maguen S, et al. Latent classes of PTSD symptoms in Vietnam veterans. Behav Modif 2012; 36: 857-74.
18. Peiris-John RJ, Wanigasuriya JK, Wickremasinghe AR, Dissanayake WP, Hittarage A. Exposure to acetylcholinesterase-inhibiting pesticides and chronic renal failure. Ceylon Med J 2006; 51: 42-3.
19. Namnyak M, Tufton N, Szekely R, et al. 'Stockholm syndrome': psychiatric diagnosis or urban myth? Acta Psychiatr Scand 2008; 117: 4-11.
20. Julich S. Stockholm syndrome and child sexual abuse. J Child Sex Abus 2005; 14: 107-29.
21. Maguen S, Madden E, Bosch J, et al. Killing and latent classes of PTSD symptoms in Iraq and Afghanistan veterans. J Affect Disord; 2012; 6.
22. Jovanovic T, Kazama A, Bachevalier J, Davis M. Impaired safety signal learning may be a biomarker of PTSD. Neuropharmacology 2012; 62: 695-704.
23. Skelton K, Ressler KJ, Norrholm SD, Jovanovic T, Bradley-Davino B. PTSD and gene variants: new pathways and new thinking. Neuropharmacology 2012; 62: 628-37.
24. Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000; 25: 1-35.
25. Mason JW, Giller EL, Kosten TR, Harkness L. Elevation of urinary norepinephrine/cortisol ratio in posttraumatic stress disorder. J Nerv Ment Dis 1988; 176: 498-502.
26. Geracioti TD Jr, Baker DG, Ekhator NN, et al. CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry 2001; 158: 1227-30.
27. Yehuda R, Siever LJ, Teicher MH, et al. Plasma norepinephrine and 3-methoxy-4-hydroxyphenylglycol concentrations and severity of depression in combat posttraumatic stress disorder and major depressive disorder. Biol Psychiatry 1998; 44: 56-63.
28. Bonne O, Gill JM, Luckenbaugh DA, et al. Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine. J Clin Psychiatry 2011; 72: 1124-8.
29. Sautter FJ, Bissette G, Wiley J, et al. Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects. Biol Psychiatry 2003; 54: 1382-8.
30. Heim C, Owens MJ, Plotsky PM, Nemeroff CB. The role of early adverse life events in the etiology of depression and posttraumatic stress disorder. Focus on corticotropin-releasing factor. Ann NY Acad Sci 1997; 821: 194-207.
31. Bremner JD, Licinio J, Darnell A, et al. Elevated CSF corticotropinreleasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry 1997; 154: 624-9.
32. de Kloet CS, Vermetten E, Geuze E, et al. Elevated plasma corticotrophin-releasing hormone levels in veterans with posttraumatic stress disorder. Prog Brain Res 2008; 167: 287-91.
33. Bancroft J, Cook A, Davidson D, Bennie J, Goodwin G. Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change. Psychol Med 1991; 21: 305-12.
34. Klaassens ER, Giltay EJ, Cuijpers P, van Veen T, Zitman FG. Adulthood trauma and HPA-axis functioning in healthy subjects and PTSD patients: a meta-analysis. Psychoneuroendocrinology 2012; 37: 317-31.
35. North CS, Pfefferbaum B, Tivis L, et al. The course of posttraumatic stress disorder in a follow-up study of survivors of the Oklahoma City bombing. Ann Clin Psychiatry 2004; 16: 209-15.
36. Ritsner MS, Mar M, Arbitman M, Grinshpoon A. Symptom severity scale of the DSM5 for schizophrenia, and other psychotic disorders: diagnostic validity and clinical feasibility. Psychiatry Res 2013; 30; 208: 1-8.
37. Green CS, Bavelier D. Exercising your brain: a review of human brain plasticity and training-induced learning. Psychol Aging 2008; 23: 692-701.
38. Rey J. Proposed changes to the psychiatric classification: towards DSM5. Australas Psychiatry 2010; 18: 309-13.
39. Yehuda R. Clinical relevance of biologic findings in PTSD. Psychiatr Q 2002; 73: 123-33.
40. Yehuda R. Biology of posttraumatic stress disorder. J Clin Psychiatry 2001; 62 Suppl 17: 41-6.
41. Brunello N, Davidson JR, Deahl M, et al. Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment. Neuropsychobiology 2001; 43: 150-62.
42. Yehuda R. Biology of posttraumatic stress disorder. J Clin Psychiatry 2000; 61 Suppl 7: 14-21.
43. Andreasen NC. Posttraumatic stress disorder: psychology, biology, and the manichaean warfare between false dichotomies. Am J Psychiatry 1995; 152: 963-5.
44. Radosevich PM, Nash JA, Lacy DB, et al. Effects of low-and highintensity exercise on plasma and cerebrospinal fluid levels of ir-betaendorphin, ACTH, cortisol, norepinephrine and glucose in the conscious dog. Brain Res 1989; 25; 498: 89-98.
45. Yau JL, Olsson T, Morris RG, Meaney MJ, Seckl JR. Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats. Neuroscience 1995; 66: 571-81.
46. Baker DG, Nievergelt CM, O'Connor DT. Biomarkers of PTSD: neuropeptides and immune signaling. Neuropharmacology 2012; 62: 663-73.
47. Suris A, North C, Adinoff B, Powell CM, Greene R. Effects of exogenous glucocorticoid on combat-related PTSD symptoms. Ann Clin Psychiatry 2010; 22: 274-9.
48. Belanoff JK, Gross K, Yager A, Schatzberg AF. Corticosteroids and cognition. J Psychiatr Res 2001; 35: 127-45.
49. Holzel BK, Carmody J, Evans KC, et al. Stress reduction correlates with structural changes in the amygdala. Social Cogn Affect Neurosci 2010; 5: 11-7.
50. Zhang L, Zhou R, Li X, Ursano RJ, Li H. Stress-induced change of mitochondria membrane potential regulated by genomic and nongenomic GR signaling: a possible mechanism for hippocampus atrophy in PTSD. Med Hypotheses 2006; 66: 1205-8.
51. Su YA, Wu J, Zhang L, et al. Dysregulated mitochondrial genes and networks with drug targets in postmortem brain of patients with posttraumatic stress disorder (PTSD) revealed by human mitochondriafocused cDNA microarrays. Int J Biol Sci 2008; 4: 223-35.
52. Kitayama N, Vaccarino V, Kutner M, Weiss P, Bremner JD. Magnetic resonance imaging (MRI) measurement of hippocampal volume in posttraumatic stress disorder: a meta-analysis. J Affect Disord 2005; 88: 79-86.
53. Bonne O, Brandes D, Gilboa A, et al. Longitudinal MRI study of hippocampal volume in trauma survivors with PTSD. Am J Psychiatry 2001; 158: 1248-51.
54. Jatzko A, Rothenhofer S, Schmitt A, et al. Hippocampal volume in chronic posttraumatic stress disorder (PTSD): MRI study using two different evaluation methods. J Affect Disord 2006; 94: 121-6.
55. Shucard JL, Cox J, Shucard DW, et al. Symptoms of posttraumatic stress disorder and exposure to traumatic stressors are related to brain structural volumes and behavioral measures of affective stimulus processing in police officers. Psychiatry Res 2012; 204: 25-31.
56. Rubin DC, Boals A, Berntsen D. Memory in posttraumatic stress disorder: properties of voluntary and involuntary, traumatic and nontraumatic autobiographical memories in people with and without posttraumatic stress disorder symptoms. J Exp Psychol Gen 2008; 137: 591-614.
57. Bohnen N, Nicolson N, Sulon J, Jolles J. Coping style, trait anxiety and cortisol reactivity during mental stress. J Psychosom Res 1991; 35: 141-7.
58. Hu J, Zhu C, Huang M. The endocannabinoid system: a new pharmacological target for obesity treatment? Neurosci Bull 2009; 25: 153-60.
59. Leung MK, Chan CC, Yin J, Lee CF, So KF, Lee TM. Increased gray matter volume in the right angular and posterior parahippocampal gyri in loving-kindness meditators. Social Cogn Affect Neurosci 2012; 16: 21.
60. Pearson DG. Contextual representations increase analogue traumatic intrusions: evidence against a dual-representation account of peritraumatic processing. J Behav Ther Exp Psychiatry 2012; 43: 1026-31.
61. Ball CLJ. A Comparison of Involuntary Autobiographical Memory Retrievals. Appl Cogn Cycol 2006; 20: 1167-79.
62. Raison CL, Miller AH. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stressrelated disorders. Am J Psychiatry 2003; 160: 1554-65.
63. Spiegel D. Dissociation in the DSM5. J Trauma Dissoc 2010; 11: 261-5.
64. Milad MR, Pitman RK, Ellis CB, et al. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol Psychiatry 2009; 66: 1075-82.
65. Back SE, Killeen T, Foa EB, et al. Use of an integrated therapy with prolonged exposure to treat PTSD and comorbid alcohol dependence in an Iraq veteran. Am J Psychiatry 2012; 169: 688-91.
66. Najavits LM, Walsh M. Dissociation, PTSD, and substance abuse: an empirical study. J Trauma Dissoc 2012; 13: 115-26.
67. Fang CY, Reibel DK, Longacre ML, et al. Enhanced psychosocial well-being following participation in a mindfulness-based stress reduction program is associated with increased natural killer cell activity. J Altern Complement Med 2010; 16: 531-8.
68. Davidson RJ, Kabat-Zinn J, Schumacher J, et al. Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med 2003; 65: 564-70.
69. Holzel BK, Carmody J, Vangel M, et al. Mindfulness practice leads to increases in regional brain gray matter density. Psychiatry Res 2011; 191: 36-43.
70. Radley JJ, Kabbaj M, Jacobson L, et al. Stress risk factors and stressrelated pathology: neuroplasticity, epigenetics and endophenotypes. Stress 2011; 14: 481-97.
71. Heyman E, Gamelin FX, Aucouturier J, Di Marzo V. The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity. Obes Rev 2012; 13: 1110-24.
72. McEwen BS, de Leon MJ, Lupien SJ, Meaney MJ. Corticosteroids, the Aging Brain and Cognition. Trends Endocrinol Metab 1999; 10: 92-6.
73. Lindley SE, Carlson EB, Benoit M. Basal and dexamethasone suppressed salivary cortisol concentrations in a community sample of patients with posttraumatic stress disorder. Biol Psychiatry 2004 1; 55: 940-5.
74. Newport DJ, Nemeroff CB. Neurobiology of posttraumatic stress disorder. Curr Opin Neurobiol 2000; 10: 211-8.
75. Wimalawansa SJ. Causes and risk factors for posttraumatic stress disorder: The importance of right diagnosis and treatment. Asian J Med Sci 2013; 5: 29-40.
76. van Praag HM. The cognitive paradox in posttraumatic stress disorder: a hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 923-35.
77. Mironova V, Rybnikova E, Pivina S. Effect of inescapable stress in rodent models of depression and posttraumatic stress disorder on CRH and vasopressin immunoreactivity in the hypothalamic paraventricular nucleus. Acta Physiol Hung 2013; 100: 395-410.
78. Strawn JR, Ekhator NN, Horn PS, Baker DG, Geracioti TD, Jr. Blood pressure and cerebrospinal fluid norepinephrine in combat-related posttraumatic stress disorder. Psychosom Med 2004; 66: 757-9.
79. Lupien SJ, Wilkinson CW, Briere S, et al. The modulatory effects of corticosteroids on cognition: studies in young human populations. Psychoneuroendocrinology 2002; 27: 401-16.
80. de Kloet ER, Oitzl MS, Joels M. Stress and cognition: are corticosteroids good or bad guys? Trends Neurosci 1999; 22: 422-6.
81. Lupien SJ, McEwen BS. The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res Brain Res Rev 1997; 24: 1-27.
82. Corvalan JC, Klein D. PTSD: diagnosis, evolution, and treatment of combat-related psychological/psychiatric injury. Mol Med 2011; 108: 296-303.
83. Aardal-Eriksson E, Eriksson TE, Thorell LH. Salivary cortisol, posttraumatic stress symptoms, and general health in the acute phase and during 9-month follow-up. Biol Psychiatry 2001; 50: 986-93.
84. Utku F, Checinski K. Predicting mental illness in soldiers: predeployment screening for vulnerability to post-traumatic stress disorder. Br Med J 2006; 333: 1123.
85. Zohar J, Juven-Wetzler A, Myers V, Fostick L. Post-traumatic stress disorder: facts and fiction. Curr Opin Psychiatry 2008; 21: 74-7.
86. Beckerman NL, Auerbach C. PTSD and HIV in women: the role of gender in this dual diagnosis. Women Health 2011; 51: 497-510.
87. de la Espriella R, Pingel ES, Falla JV. The (de)construction of a psychiatric diagnosis: PTSD among former guerrilla and paramilitary soldiers in Colombia. Global Pub Health 2010; 19: 1-12.
88. Adeponle AB, Thombs BD, Groleau D, Jarvis E, Kirmayer LJ. Using the cultural formulation to resolve uncertainty in diagnoses of psychosis among ethnoculturally diverse patients. Psychiatr Serv 2012; 63: 147-53.
89. Olszewski TM, Varrasse JF. The neurobiology of PTSD: implications for nurses. J Psychosoc Nurs Ment Health Serv 2005; 43: 40-7.
90. Balducci C, Fraccaroli E. Comparison between the risk of mobbing at work and conditions of job strain and effort-reward imbalance in relation to stress-related disorders: a study in the public administration. Med Lav 2013; 104: 44-54.
91. Brown ES, Frol A, Bobadilla L, et al. Effect of lamotrigine on mood and cognition in patients receiving chronic exogenous corticosteroids. Psychosomatics 2003; 44: 204-8.
92. Munhoz CD, Garcia-Bueno B, Madrigal JL, et al. Stress-induced neuroinflammation: mechanisms and new pharmacological targets. Braz J Med Biol Res 2008; 41: 1037-46.
93. Baker DG, Ekhator NN, Kasckow JW, et al. Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder. Neuroimmunomodulation 2001; 9: 209-17.
94. Friedman EH. The neurobiology of posttraumatic stress disorder (PTSD). Biol Psychiatry 1994; 35: 500.
95. Hammack SE, Cooper MA, Lezak KR. Overlapping neurobiology of learned helplessness and conditioned defeat: implications for PTSD and mood disorders. Neuropharmacology 2012; 62: 565-75.
96. Lipov E, Kelzenberg B. Sympathetic system modulation to treat posttraumatic stress disorder (PTSD): A review of clinical evidence and neurobiology. J Affect Disord 2012; 142: 1-5.
97. Xiao B, Yu B, Wang HT, Han F, Shi YX. Single-prolonged stress induces apoptosis by activating cytochrome C/caspase-9 pathway in a rat model of post-traumatic stress disorder. Cell Mol Neurobiol 2011; 31: 37-43.
98. Xiao B, Han F, Wang HT, Shi YX. Single-prolonged stress induces increased phosphorylation of extracellular signal-regulated kinase in a rat model of post-traumatic stress disorder. Mol Med Rep 2011; 4: 445-9.
99. Li XM, Han F, Liu DJ, Shi YX. Single-prolonged stress induced mitochondrial-dependent apoptosis in hippocampus in the rat model of post-traumatic stress disorder. J Chem Neuroanat 2010; 40: 248-55.
100. Naviaux RK. Metabolic features of the cell danger response. Mitochondrion 2013; 24, 1085.
101. Hajduczki A, Majumdar S, Fricke M, Brown IA, Weiss GA. Solubilization of a membrane protein by combinatorial supercharging. ACS Chem Biol 2011; 6: 301-7.
102. Tezcan E, Atmaca M, Kuloglu M, Ustundag B. Free radicals in patients with post-traumatic stress disorder. Eur Arch Psychiatry Clin Neurosci 2003; 253: 89-91.
103. Jia M, Meng F, Smerin SE, et al. Biomarkers in an animal model for revealing neural, hematologic, and behavioral correlates of PTSD. J Visual Exp 2012 (68): 1327.
104. Mograbi GJ. Meditation and the brain: attention, control and emotion. Mens sana monographs 2011; 9: 276-83.
105. Lazar SW, Kerr CE, Wasserman RH, et al. Meditation experience is associated with increased cortical thickness. Neuroreport 2005; 16: 1893-7.
106. Vestergaard-Poulsen P, van Beek M, Skewes J, et al. Long-term meditation is associated with increased gray matter density in the brain stem. Neuroreport 2009; 20: 170-4.
107. Nardo D, Hogberg G, Lanius RA, et al. Gray matter volume alterations related to trait dissociation in PTSD and traumatized controls. Acta Psychiatr Scand 2012; 25: 1974.
108. Salvadori MC, Teixeira FS, Sgubin LG, et al. Performance of an inverted ion source. Rev Sci Instrum 2013; 84: 023506.
109. Wimalawansa SJ. Buddhist Meditation Practices; Karu Sons, Homagama, Sri Lanka; 2012; p. 580.
110. Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med 2003; 65: 571-81.
111. Speca M, Carlson LE, Goodey E, Angen M. A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 2000; 62: 613-22.
112. Lutz A, Greischar LL, Rawlings NB, Ricard M, Davidson RJ. Longterm meditators self-induce high-amplitude gamma synchrony during mental practice. Proc Natl Acad Sci USA 2004; 101: 16369-73.
113. Wimalawansa SJ. Meditation for Everyone: A Guide to Personal Happiness; Karunaratne & Sons, Homagama, Sri Lanka, 2012.
114. Moore A, Gruber T, Derose J, Malinowski P. Regular, brief mindfulness meditation practice improves electrophysiological markers of attentional control. Front Human Neurosci 2012; 6: 18.
115. Ospina MB, Bond K, Karkhaneh M, et al. Clinical trials of meditation practices in health care: characteristics and quality. J Altern Complement Med 2008; 14: 1199-213.
116. Zautra AJ, Davis MC, Reich JW, et al. Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression. J Consult Clin Psychol 2008; 76: 408-21.
117. Barnes VA, Pendergrast RA, Harshfield GA, Treiber FA. Impact of breathing awareness meditation on ambulatory blood pressure and sodium handling in prehypertensive African American adolescents. Ethn Dis 2008; 18: 1-5.
118. Gregoski MJ, Barnes VA, Tingen MS, Harshfield GA, Treiber FA. Breathing awareness meditation and LifeSkills Training programs influence upon ambulatory blood pressure and sodium excretion among African American adolescents. J Adolesc Health 2011; 48: 59-64.
119. Ursin H, Eriksen HR. Cognitive activation theory of stress (CATS). Neurosci Biobehav Rev 2010; 34: 877-81.
120. Ursin H, Eriksen HR. The cognitive activation theory of stress. Psychoneuroendocrinology 2004; 29: 567-92.
121. Ursin H. The development of a Cognitive Activation Theory of Stress: from limbic structures to behavioral medicine. Scand J Psychol 2009; 50: 639-44.